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Imaging
Myocardial Steatosis and Biventricular Strain and Strain
Rate Imaging in Patients With Type 2 Diabetes Mellitus
Arnold C.T. Ng, MBBS; Victoria Delgado, MD, PhD; Matteo Bertini, MD, PhD;
Rutger W. van der Meer, MD, PhD; Luuk J. Rijzewijk, MD; See Hooi Ewe, MBBS;
Hans-Marc Siebelink, MD, PhD; Johannes W.A. Smit, MD, PhD; Michaela Diamant, MD, PhD;
Johannes A. Romijn, MD, PhD; Albert de Roos, MD, PhD; Dominic Y. Leung, MBBS, PhD;
Hildo J. Lamb, MD, PhD; Jeroen J. Bax, MD, PhD
Background—Magnetic resonance spectroscopy can quantify myocardial triglyceride content in type 2 diabetic patients.
Its relation to alterations in left (LV) and right (RV) ventricular myocardial functions is unknown.
Methods and Results—A total of 42 men with type 2 diabetes mellitus were recruited. Exclusion criteria included
hemoglobin A1c 8.5%, known cardiovascular disease, diabetes-related complications, or blood pressure 150/
85 mm Hg. Myocardial ischemia was excluded by a negative dobutamine stress test. LV and RV volumes and ejection
fraction were quantified by magnetic resonance imaging. LV global longitudinal and RV free wall longitudinal strain,
systolic strain rate, and diastolic strain rate were quantified by echocardiographic speckle tracking analyses. Myocardial
triglyceride content was quantified by magnetic resonance spectroscopy and dichotomized on the basis of the median
value of 0.76%. The median age was 59 years (25th and 75th percentiles, 54 and 62 years). Median diabetes diagnosis duration
was 4 years, and median glycohemoglobin level was 6.2% (25th and 75th percentiles, 5.9% and 6.8%). There were no
differences in LV and RV end-diastolic and end-systolic volume indexes and ejection fraction between patients with high
(0.76%) and those with low (0.76%) myocardial triglyceride content. However, patients with high myocardial triglyceride
content had greater impairment of LV and RV myocardial strain and strain rate. The myocardial triglyceride content was an
independent correlate of LV and RV longitudinal strain, systolic strain rate, and diastolic strain rate.
Conclusions—High myocardial triglyceride content is associated with more pronounced impairment of LV and RV
functions in men with uncomplicated type 2 diabetes mellitus. (Circulation. 2010;122:2538-2544.)
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The pathogenic mechanisms underlying diabetic heartdisease are likely to be multifactorial, ranging from
altered myocardial metabolism to endothelial dysfunction,
microvascular disease, autonomic neuropathy, and altered
myocardial structure with fibrosis.1 Increasing evidence is
emerging on the role of altered myocardial metabolism with
subsequent lipotoxic injury from lipid oversupply. Recent
studies have evaluated the role of myocardial triglyceride
accumulation (steatosis) and diastolic dysfunction in patients
with type 2 diabetes mellitus.2,3 Although differences in
transmitral flow patterns indicative of diastolic dysfunction
were seen in diabetics compared with normal control sub-
jects, there was no significant difference in global systolic
function as determined by ejection fraction (EF).2,3 In con-
trast, strain imaging and strain rate (SR) imaging are more
sensitive indexes of myocardial function and have been
shown to be impaired in diabetic patients.4–10 However, no
studies to date have evaluated the relationship between myocar-
dial triglyceride content and both left (LV) and right ventricular
(RV) myocardial functions. Therefore, the aim of the present
study was to relate myocardial triglyceride content as deter-
mined by magnetic resonance (MR) spectroscopy with biven-
tricular myocardial strain and SR as determined by echocardio-
graphic 2-dimensional (2D) speckle tracking analysis.
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Methods
Patient Sample
The original Pioglitazone Influence on Triglyceride Accumulation in
the Myocardium in Diabetes (PIRAMID) trial included a total of 78
diabetic patients recruited from 2 centers (Leiden University Medical
Center, Leiden, and VU University Medical Center, Amsterdam, the
Netherlands).11 The present study included only 42 diabetic patients
who underwent a comprehensive MR (including spectroscopy) and
echocardiographic examination at baseline from a single center
(Leiden University Medical Center).
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The inclusion and exclusion criteria have previously been reported.11
Briefly, only male diabetics were recruited to avoid possible con-
founding influences of female gender and plasma estrogen levels on
lipid metabolism and myocardial triglyceride accumulation. Inclu-
sion criteria included type 2 diabetes mellitus diagnosed according to
World Health Organization criteria12 and treated with sulfonylurea
derivatives in stable doses, glycohemoglobin level between 6.5% and
8.5%, and resting blood pressure 150/85 mm Hg with or without
antihypertensive medication. In addition, as an inclusion criterion,
the presence of myocardial ischemia was excluded in all patients by a
negative high-dose dobutamine stress echocardiogram.3 Exclusion cri-
teria included known cardiovascular disease or diabetes-related compli-
cations, including proliferative retinopathy, autonomic neuropathy as
excluded by Ewing tests,13 and microalbuminuria as excluded by
measurements of albumin-to-creatinine ratio in a urine sample.
Study Protocol
All patients underwent MR imaging (MRI) examinations with MR
spectroscopy and transthoracic echocardiography at baseline. Both
LV and RV volumes and EFs were quantified by MRI, whereas LV
and RV myocardial strain and SR were quantified by echocardio-
graphic 2D speckle tracking analyses. The myocardial triglyceride
content was measured by MR spectroscopy, and the study sample
was then dichotomized into 2 groups based on the median value.
Biventricular volumes, EF, and myocardial strain/SR were then
compared between the 2 groups, and independent correlates of LV
and RV myocardial functions were identified.
Cardiac MRI Protocol
All patients underwent MRI examinations for assessment of biven-
tricular volumes and functions and myocardial triglyceride content
after an overnight fast with a 1.5-T whole-body MR scanner
(Gyroscan ACS/NT15; Philips, Best, the Netherlands). During the
examinations, the entire heart was imaged in the short-axis orienta-
tion with ECG-gated breath-hold– balanced steady-state free-
precession imaging. Imaging parameters included the following:
echo time, 1.7 milliseconds; repetition time, 3.4 milliseconds; flip
angle, 35°; slice thickness, 10 mm with a gap of 0 mm; field of view,
400400 mm; and reconstructed matrix size, 256256.
LV and RV end-diastolic volume index and end-systolic volume
index were measured and corrected for body surface area.14 LVEF
and RVEF were then calculated and expressed as percentages. LV
mass (excluding papillary muscles) was also measured and indexed
to body surface area. LV mass-cavity ratio (which is conceptually
similar to relative wall thickness) was calculated as previously
described, with a higher mass-cavity ratio indicating increasing
relative wall thickness.15 All images were digitally stored on hard
disks and analyzed offline with dedicated quantitative software
(MASS, Medis, Leiden, the Netherlands).
Cardiac Proton MR Spectroscopy
Cardiac proton MR spectroscopy ([1H]-MRS) was performed as
previously described.16 Briefly, myocardial [1H]-MRS spectra were
obtained from the interventricular septum to avoid contamination
from epicardial fat. Spectroscopic data acquisitions were double-
triggered with ECG triggering and respiratory navigator echoes to
minimize motion artifacts. Water-suppressed spectra were acquired
to measure myocardial triglyceride content, and spectra without
water suppression were acquired and used as an internal standard.16
[1H]-MRS data were fitted by use of Java-based MR user interface
software (jMRUI version 2.2, Leuven, Belgium) as previously
described.16 Myocardial triglyceride content relative to water was
calculated and expressed as a percentage based on the following:
signal amplitude of triglyceride divided by signal amplitude of
water100.16
Echocardiography
Transthoracic echocardiography was performed with the subjects at
rest using commercially available ultrasound transducer and equip-
ment (M3S probe, Vivid 7, GE-Vingmed, Horten, Norway). All
images were digitally stored on hard disks for offline analysis
(EchoPAC version 108.1.5, GE-Vingmed). A complete 2D, color,
pulsed, and continuous-wave Doppler echocardiogram was per-
formed according to standard techniques.17,18
Evaluation of the traditional parameters of LV diastolic function
was performed by assessing transmitral inflow and pulmonary
venous velocities using conventional pulsed-wave Doppler echocar-
diography in the apical 4-chamber view with a 2-mm sample
volume. Transmitral early (E-wave) and late (A-wave) diastolic
velocities and deceleration time were recorded at the mitral leaflet
tips. LV isovolumic relaxation time was also recorded. The pulmo-
nary venous peak systolic and diastolic velocities were recorded with
the sample volume positioned 1 cm below the orifice of the right
superior pulmonary vein in the left atrium.
Two-Dimensional Speckle Tracking
We performed 2D speckle tracking analyses on standard echocar-
diographic gray-scale images. LV longitudinal function was deter-
mined from the 3 apical (2-, 3-, and 4-chamber) views, whereas the
RV free wall longitudinal function was determined from the apical
4-chamber view only (the Figure). During analysis, the endocardial
border was manually traced at end systole, and the region of interest
width was adjusted to include the entire myocardium. The software
then automatically tracks and accepts segments of good tracking
quality and rejects poorly tracked segments while allowing the
observer to manually override its decisions on the basis of visual
assessments of tracking quality. Peak longitudinal strain, peak
systolic SR, and peak early diastolic SR for both the LV and RV
myocardium were determined. We calculated mean LV global
longitudinal strain/SR from the 3 individual apical global longitudi-
nal strain/SR curves and obtained RV free wall longitudinal
strain/SR from the apical 4-chamber view. All strain and SR
measurements were exported to a spreadsheet (Microsoft Excel
2002, Microsoft Corp, Redmond, Wash).
Previous work has reported the intraobserver and interobserver
variabilities in our laboratory as expressed by mean absolute differ-
ence for longitudinal strain (1.20.5% and 0.91.0%), systolic SR
(0.100.06 and 0.090.08 second1), and early diastolic SR
(0.080.05 and 0.130.09 second1).10
The study was approved by the local institutional ethics commit-
tee. Written informed consent was obtained from all patients.
Statistical Analysis
Because of the relatively small number of patients, all continuous
variables were presented as median and 25th and 75th percentiles.
The Mann-Whitney U test was used to compare 2 groups of unpaired
data. Multivariable linear regression analysis was used to identify
independent correlates of LV and RV strain/SR. To generate the
multivariable models, univariate variables with a value of P0.20
were entered as covariates. To avoid multicollinearity between the
univariate correlates, a tolerance level of 0.5 (corresponding to a
correlation coefficient of 0.7) was set. A 2-tailed value of P0.05
was considered significant. All statistical analyses were performed
with SPSS for Windows, version 17 (SPSS Inc, Chicago, Ill).
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
The median age was 59 years (25th and 75th percentiles, 54
and 62 years), and the median diabetes diagnosis duration
was 4 years (range, 1 to 11 years). The mean myocardial
triglyceride content was 0.780.42%. When the study sam-
ple was dichotomized on the basis of the median myocardial
triglyceride level of 0.76%, there were no significant differ-
ences in blood glucose level, glycohemoglobin levels, and
lipid profiles between the 2 groups (Table 1).
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LV Volumes and Functions
Table 2 summarizes the LV volumes and EFs derived from
MRI and LV myocardial strain and SR derived from echo-
cardiographic 2D speckle tracking analyses. There were no
significant differences in LV volumes and EFs between
patients with high and those with low myocardial triglyceride
content. In addition, there were no differences in LV mass
index (48.1 g/m2 [46.5 and 53.1 g/m2] versus 50.9 g/m2 [46.5
and 55.8 g/m2]; P0.37) and LV mass-cavity ratio (0.70
[0.61 and 0.80] versus 0.73 [0.61 and 0.79]; P0.79) be-
tween the 2 groups of patients. Similarly, there were no
significant differences in traditional parameters of LV dia-
stolic function, including transmitral E/A ratio (0.89 [0.75
and 1.11] versus 0.97 [0.72 and 1.12]; P0.97), deceleration
time (206 ms [157 and 214 ms] versus 192 ms [165 and 203
ms]; P0.35), isovolumic relaxation time (84 ms [77 and 94
ms] versus 78 ms [73 and 92 ms]; P0.44), and pulmonary
systolic-to-diastolic ratio (1.45 [1.23 and 1.68] versus 1.35
[1.17 and 1.64]; P0.37) between the 2 groups of patients.
However, patients with higher myocardial triglyceride con-
tent had greater impairment of global LV longitudinal strain
and SR (Table 2).
To identify the independent correlates of global LV longi-
tudinal strain and SR, univariate correlates with a value of
P0.20 (age, systolic blood pressure, fasting blood glucose
level, high-density lipoprotein cholesterol, low-density li-
poprotein cholesterol, and myocardial triglyceride content)
were all entered into multiple linear regression models. Total
cholesterol was not included in the model because of high
collinearity with low-density lipoprotein cholesterol. Table 3
shows that the myocardial triglyceride content measured by
MR spectroscopy was an independent correlate of global LV
longitudinal strain, systolic SR, and diastolic SR.
RV Volumes and Functions
Table 2 summarizes the RV volumes, EFs, free wall longi-
tudinal strain, and SR. Similarly, there were no significant
differences in MRI-derived RV volumes and EFs between the
Figure. Graphic example of the speckle tracking analyses to derive LV and RV ventricular myocardial strain and SR measurements.
Mean LV global longitudinal strain/SR was calculated from the 3 individual (4-, 2-, and 3-chamber) strain/SR curves, whereas the RV
free wall strain/SR was derived from the 4-chamber view only. The mean global LV longitudinal strain, systolic SR, and diastolic SR
were 16.6%, 0.85 s1, and 1.01 s1, respectively. The mean RV free wall longitudinal strain, systolic SR, and diastolic SR were
29.0%, 1.30 s1, and 1.31 s1, respectively.
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2 groups of patients. However, patients with higher myocar-
dial triglyceride content had greater impairment of RV free
wall longitudinal strain and SR.
To identify independent correlates of RV free wall longitudi-
nal strain and SR, age, fasting blood glucose level, high-density
lipoprotein cholesterol, low-density lipoprotein cholesterol, and
myocardial triglyceride content were all entered into the multiple
linear regression models. Table 4 shows that myocardial triglyc-
eride content was an independent correlate of RV free wall
longitudinal strain, systolic SR, and diastolic SR.
Discussion
In the present study, MRI assessment revealed similar LV/RV
volumes and EFs in type 2 diabetic patients with high versus
low myocardial triglyceride content as measured by MR
spectroscopy. However, 2D speckle tracking deformation
imaging demonstrated greater impairments of biventricular
strain/SR in patients with higher myocardial triglyceride
content. Myocardial triglyceride content was an independent
correlate of LV and RV longitudinal strain, systolic SR, and
diastolic SR.
Table 1. Clinical and Biochemical Characteristics
Variable
Total
Sample (n42)
Low Myocardial
Triglycerides (n21)
High Myocardial
Triglycerides (n21) P
Clinical
Age, y 59 (54–62) 58 (51–62) 60 (55–63) 0.20
Body mass index, kg/m2 26.9 (25.0–30.2) 26.9 (25.0–28.9) 26.6 (25.0–31.1) 0.67
Body surface area, m2 2.08 (2.00–2.22) 2.10 (2.01–2.20) 2.06 (1.97–2.25) 0.89
Waist circumference, cm 98.5 (93.9–106.0) 98.0 (93.0–103.0) 102.0 (95.0–108.0) 0.26
Diabetes duration, y 4.0 (1.0–7.3) 3.0 (1.5–7.0) 4.0 (1.0–7.5) 0.83
Heart rate, bpm 71 (65–82) 72 (66–82) 70 (64–80) 0.68
Systolic blood pressure, mm Hg 139 (130–144) 134 (126–140) 141 (133–148) 0.025
Diastolic blood pressure, mm Hg 77 (71–82) 77 (71–84) 76 (73–81) 0.83
Biochemical
Blood glucose, mmol/L 8.2 (7.3–9.8) 8.1 (7.4–9.0) 8.4 (7.1–10.9) 0.35
Glycated hemoglobin, % 6.2 (5.9–6.8) 6.2 (5.9–6.9) 6.0 (5.9–6.7) 0.61
Plasma triglycerides, mmol/L 1.50 (0.90–2.30) 1.10 (0.85–2.05) 1.80 (1.40–2.80) 0.059
Total cholesterol, mmol/L 4.60 (3.90–5.10) 4.30 (3.85–4.75) 4.90 (4.00–5.30) 0.070
High-density lipoprotein cholesterol, mmol/L 1.16 (0.98–1.40) 1.24 (1.01–1.44) 1.10 (0.89–1.24) 0.097
Low-density lipoprotein cholesterol, mmol/L 2.55 (2.00–3.05) 2.40 (1.95–2.90) 2.90 (2.05–3.55) 0.17
Table 2. LV and RV Volumes, EF, Strain, and SR
Variable
Total
Sample (n42)
Low Myocardial
Triglycerides (n21)
High Myocardial
Triglycerides (n21) P
Left ventricle
Magnetic resonance imaging
LVEDVI, mL/m2 71.6 (64.5–78.1) 73.2 (66.6–80.8) 68.0 (63.4–78.3) 0.31
LVESVI, mL/m2 32.0 (27.6–37.0) 32.2 (30.0–37.3) 31.1 (25.6–36.3) 0.23
LVEF, % 54.6 (51.3–58.1) 54.0 (50.5–56.8) 55.1 (52.8–58.8) 0.22
2D speckle tracking
LV global strain, % 17.9 (17.0–19.6) 19.3 (18.5–20.1) 17.1 (16.3–17.7) 0.001
LV global systolic SR, s1 0.98 (0.87–1.06) 1.02 (0.96–1.14) 0.87 (0.82–0.98) 0.001
LV global diastolic SR, s1 1.05 (0.91–1.16) 1.11 (1.05–1.23) 0.93 (0.77–1.11) 0.003
Right ventricle
Magnetic resonance imaging
RVEDVI, mL/m2 70.7 (63.9–73.9) 71.1 (64.0–76.7) 69.3 (63.6–73.0) 0.43
RVESVI, mL/m2 33.2 (30.1–35.9) 34.9 (30.2–36.9) 31.9 (29.0–35.8) 0.31
RVEF, % 52.0 (49.5–53.7) 52.0 (49.6–53.4) 53.0 (48.8–54.4) 0.63
2D speckle tracking
RV free wall strain, % 26.2 (23.5–28.4) 27.7 (25.1–30.2) 24.5 (19.0–27.7) 0.016
RV free wall systolic SR, s1 1.83 (1.62–2.23) 2.11 (1.77–2.46) 1.74 (1.44–1.85) 0.005
RV free wall diastolic SR, s1 1.79 (1.44–2.21) 2.10 (1.75–2.61) 1.65 (1.12–1.86) 0.001
EDVI indicates end-diastolic volume index; ESVI, end-systolic volume index.
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Myocardial Substrate Metabolism and Steatosis
The origin of diabetic heart disease is complex and multifac-
torial, ranging from altered myocardial metabolism to up-
regulation of the renin-angiotensin system, increased oxida-
tive stress, endothelial dysfunction with microvascular
disease, autonomic neuropathy, and altered myocardial struc-
ture with fibrosis.1 However, recent evidence suggests the
role of myocardial lipotoxic injury from lipid oversupply in
contributing to diabetic heart disease.19
Under normal physiological conditions, fatty acids are
absorbed through the intestines and stored as triglycerides
within adipocytes with minimal accumulation within nona-
dipose tissues such as the heart. However, the combination
of diabetes mellitus and its metabolic derangements, insu-
lin resistance, visceral adiposity, and increased dietary
fatty acid intake leads to increased myocardial fatty acid
delivery and uptake. This results in the accumulation of
intracellular triglycerides within the myocyte cytoplasm
(also known as steatosis).19 –22 However, part of the excess
fatty acid is redirected into nonoxidative pathways, giving
rise to toxic fatty acid intermediates such as ceramide.
These toxic fatty acid intermediates disrupt normal cellular
signaling, leading to mitochondrial dysfunction, cellular
damage, apoptosis, and eventual replacement fibrosis and
myocardial contractile dysfunction. Thus, although it is
currently accepted that intracellular triglycerides are prob-
ably inert, the intracellular concentration is reflective of an
increased concentration of toxic fatty acid intermediates.
Therefore, the observed relationship between intracellular
triglyceride accumulation and myocardial dysfunction
likely represents an association mediated by the accumu-
lation of toxic intermediates from increased nonoxidative
fatty acid metabolism. Although animal studies have
shown an association between myocardial triglyceride
accumulation, eccentric LV hypertrophy, and systolic dys-
function,23 human studies showing similar association
between myocardial steatosis and myocardial dysfunction
have been limited.
Myocardial Steatosis and Myocardial Dysfunction
Several studies have examined the relationship between
myocardial triglyceride accumulation and LV function.2,3
McGavock and coworkers showed that there was no associ-
ation between myocardial triglyceride accumulation and LV
diastolic function.2 However, their results could be con-
founded by their inclusion of a heterogeneous group of
diabetic patients and the use of insulin (a lipogenic agent).2 In
contrast, Rijzewijk and coworkers were able to demonstrate
diastolic dysfunction in a group of uncomplicated diabetic
patients with myocardial steatosis compared with healthy
control subjects.3 However, both groups could not demon-
strate a correlation between myocardial triglyceride content
and LVEF.2,3 Thus, these diabetic patients have traditionally
been labeled as having diastolic dysfunction with normal
systolic function. However, this is largely a misnomer be-
cause of the insensitivity of conventional systolic parameters
such as LVEF in identifying subtle changes in myocardial
contractility.24 In contrast, 2D speckle tracking–derived myo-
cardial strain and SR indexes are more sensitive in detecting
subclinical myocardial dysfunction and have been shown to
be impaired in diabetic patients compared with normal
control subjects.4,8,10
To date, no studies have related myocardial strain and SR
analyses by echocardiography to myocardial triglyceride
Table 3. Independent Correlates of LV Global Longitudinal Strain, Global Longitudinal Systolic Strain Rate,
and Global Longitudinal Diastolic Strain Rate
Variable
Global LV
Longitudinal Strain
Global LV
Longitudinal Systolic SR
Global LV
Longitudinal Diastolic SR
Standardized  P Standardized  P Standardized  P
Age 0.197 0.28 0.092 0.62 0.179 0.27
Systolic blood pressure 0.034 0.82 0.104 0.49 0.003 0.98
Blood glucose 0.192 0.23 0.209 0.20 0.455 0.003
High-density lipoprotein cholesterol 0.146 0.43 0.043 0.82 0.003 0.99
Low-density lipoprotein cholesterol 0.161 0.27 0.197 0.19 0.054 0.67
Myocardial triglyceride content 0.373 0.036 0.373 0.039 0.326 0.038
Table 4. Independent Correlates of RV Free Wall Longitudinal Strain, Free Wall Longitudinal Systolic SR,
and Free Wall Longitudinal Diastolic SR
Variable
RV Free Wall
Longitudinal Strain
RV Free Wall
Longitudinal Systolic SR
RV Free Wall
Longitudinal Diastolic SR
Standardized  P Standardized  P Standardized  P
Age 0.084 0.67 0.280 0.098 0.050 0.76
Blood glucose 0.064 0.73 0.162 0.30 0.014 0.92
High-density lipoprotein cholesterol 0.094 0.69 0.354 0.048 0.425 0.017
Low-density lipoprotein cholesterol 0.096 0.57 0.331 0.024 0.288 0.044
Myocardial triglyceride content 0.457 0.020 0.321 0.048 0.403 0.013
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accumulation. In the present study, MRI-derived LV volumes
and EFs were similar between patients with high and those
with low myocardial triglyceride levels. However, this study
is first to demonstrate that patients with high myocardial
triglyceride levels have significantly greater impairment of
LV myocardial longitudinal strain, systolic SR, and diastolic
SR. Furthermore, because the diabetic metabolic derange-
ments with subsequent myocardial steatosis should hypothet-
ically have a similar adverse effect on the RV, the present
study also demonstrates RV free wall myocardial systolic and
diastolic dysfunctions in patients with high myocardial tri-
glyceride levels. The present study is first to demonstrate an
independent association between myocardial triglyceride
accumulation in diabetic patients and biventricular myo-
cardial dysfunctions. However, intracellular surplus tri-
glyceride itself is likely to be relatively inert, whereas the
lipid intermediates derived from nonoxidative pathways
are probably responsible for lipotoxic injury and eventual
cellular apoptosis.20 Thus, the observed relationship be-
tween myocardial triglyceride accumulation and myocar-
dial dysfunction is probably an association secondary to
the adverse diabetic metabolic profile rather than a causal
relationship.
Clinical Implications
The novel aspect of the present study is the demonstration of
the independent association between myocardial triglyceride
content and biventricular myocardial systolic and diastolic
functions. In animal studies, therapeutic interventions aiming
at reducing myocardial triglyceride accumulation have dem-
onstrated beneficial myocardial effects.23 Thus, future human
studies assessing the effectiveness of antisteatotic therapy in
type 2 diabetics may include quantifications of myocardial
triglyceride content by spectroscopy and assessments of
myocardial functions by strain/SR imaging on 2D speckle
tracking echocardiography.
Study Limitations
This was a relatively small study, and several characteristics
such as LV and RV volumes were not statistically different
between patients with high and those with low myocardial
triglyceride content. Thus, future studies should include more
patients to avoid possible type 1 error.
Conclusions
Uncomplicated type 2 diabetic patients with high levels of
myocardial triglyceride content and no ischemia showed
greater impairments of biventricular myocardial strain and
SR but biventricular volumes and EFs similar to those of
patients with low levels of myocardial triglyceride. Myocar-
dial triglyceride accumulation was an independent correlate
of biventricular myocardial strain and SR.
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CLINICAL PERSPECTIVE
The underlying origin of diabetic heart disease is likely to be multifactorial, ranging from altered myocardial metabolism
to endothelial dysfunction, microvascular disease, autonomic neuropathy, and altered myocardial structure with fibrosis.
Increasing evidence is emerging on the role of lipotoxic myocardial injury from lipid oversupply. Using magnetic
resonance imaging and proton magnetic resonance spectroscopy, the present study evaluated the association between
myocardial triglyceride accumulation and altered biventricular myocardial function by 2-dimensional speckle tracking
echocardiography in type 2 diabetic patients. Diabetic patients with high myocardial triglyceride content had significantly
more impaired biventricular myocardial functions despite normal volumes and ejection fraction. On multivariate analyses,
myocardial triglyceride content was an independent determinant of biventricular myocardial functions. Future studies
assessing the effectiveness of antisteatotic therapy in type 2 diabetic patients may include quantifications of myocardial
triglyceride content by spectroscopy and assessments of myocardial functions by strain/strain rate imaging on
2-dimensional speckle tracking echocardiography.
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